Skip To Main Content
Virander Singh Chauhan on Muck Rack

Virander Singh Chauhan

As seen in: The Hindu, Moneycontrol, Financial Express, Scroll.in, ThePrint, The Hans India, Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Virander Singh

Contact Virander Singh, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

HIV drug lenacapavir is a breakthrough in treating AIDS

|
By Virander Singh Chauhan
| Scroll.in Verified
A significant breakthrough in treating the Human Immunodeficiency Virus came recently with the US Federal Drug Administration approving lenacapavir, a new prototype medication. It uses a unique mechanism of twice-yearly injections to treat individuals with multidrug-resistant HIV. The development of lenacapavir by Gilead Sciences has been described by the journal Science as the 2024 Breakthrough of the Year.
Open in Who Shared Issue with article?

Conformationally restricted, dipeptide-based, self-assembled nanoparticles for efficient vancomycin delivery

|
By Nitin Yadav, Utkarsh Kumar, Virander Singh Chauhan
| Future Medicine Verified
https://orcid.org/0000-0003-0537-416X Molecular Medicine Group, International Centre for Genetic Engineering & Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India Delhi Institute of Pharmaceutical Sciences & Research, Mehrauli-Badarpur Road, Sector-3, Pushpvihar, New Delhi, 110017, India
Open in Who Shared Issue with article?

Paving the way for a global malaria vaccine

|
By Paushali Mukherjee, Virander Singh Chauhan
| The Hans India Verified
Malaria impacts India more than anywhere else in southeast Asia, but relief could be on the way if the early promise of vaccines in development is fulfilled. Malaria remains a deadly disease around the world, primarily affecting children below the age of five. In southeast Asia, India is bearing the brunt, accounting for 80 percent of the region's malaria burden.
Open in Who Shared Issue with article?
See all 9 articles